---
title: "Cytokine Modulators"
ocid: "ocds-r6ebe6-0000633256"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000633256"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000633256.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000633256.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (\"NSS\")"
published: "2020-10-13"
---

# Cytokine Modulators

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")  
Current stage: Award  
OCID: ocds-r6ebe6-0000633256

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000633256)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000633256.json)

## Summary

The procurement process titled "Cytokine Modulators" was initiated by NHS National Services Scotland (NSS), located at Gyle Square, Edinburgh. This open tender, relating to the health industry, aimed to supply various cytokine modulators—including etanercept, infliximab, and adalimumab—to entities under the National Health Service (Scotland). The procurement has reached the award stage; however, it has been subsequently cancelled. For reference, the relevant tender identification is NP47920, and it was last updated on 13 October 2020.

This tender presents a significant opportunity for pharmaceutical and medical supply businesses looking to expand their reach within the Scottish healthcare sector. Companies that specialise in the production or distribution of cytokine modulators and related healthcare products would be well-suited to participate in future tenders of a similar nature. Engaging with the NHS could lead to long-term relationships and substantial growth potential in this specialised field of health supply.

## Notice

Supply of Cytokine Modulators to NHS Scotland. etanercept infliximab adalimumab methotrexate The goods have been split into eight (8) categories, each of which are identified as a 'Lot'. Full details of each Lot are contained in section II.2) of this notice.

### Lot Information

Adalimumab

Supply of Adalimumab to NHS Scotland. The authority intends to award this lot as a unranked multi-supplier framework per line to a maximum of six (6) framework participants. Full details of goods and volumes can be found within the ITT documents.

Infliximab IV

Supply of Infliximab IV to NHS Scotland. The authority intends to award this Lot as a unranked multi-supplier per line to a maximum of five (5) framework participants. Full details of goods and volumes can be found within the ITT documents.

Methotrexate (50 mg per 1 ml Concentration) Pre-filled Self Injection Device

Supply of methotrexate (50 mg per 1 ml concentration) pre-filled self injection device to NHS Scotland. The authority intends to award this lot as a unranked multi-supplier framework per lot to a maximum of three (3) framework participants. Full details of goods and volumes can be found within the ITT documents.

Methotrexate (50 mg per 1 ml Concentration) Pre-filled Syringes

Supply of Methotrexate (50 mg per 1 ml concentration) pre-filled syringes to NHS Scotland. The authority intends to award this lot as a unranked multi-supplier framework per lot to a maximum of three (3) framework participants. Full details of goods and volumes can be found within the ITT documents.

Methotrexate (25 mg per 1 ml Concentration) Pre-filled Self Injection Device

Supply of methotrexate (25 mg per 1 ml concentration) pre-filled self injection device to NHS Scotland. The authority intends to award this lot as a unranked multi-supplier framework per lot to a maximum of three (3) framework participants. Full details of goods and volumes can be found within the ITT documents.

Methotrexate (25 mg per 1 ml Concentration) Pre-filled Syringes

Supply of methotrexate (25 mg per 1 ml concentration) pre-filled syringes to NHS Scotland. The authority intends to award this lot as a unranked multi-supplier framework per lot to a maximum of three (3) framework participants. Full details of goods and volumes can be found within the ITT documents.

Infliximab Subcutaneous

Supply of Infliximab Subcutaneous to NHS Scotland. The authority intends to award this lot as a single supplier framework per line. Full details of Goods and volumes can be found within the ITT documents.

Etanercept

Supply of Etanercept to NHS Scotland. The authority intends to award this lot as a unranked multi-supplier framework per line to a maximum of three (3) framework participants. Full details of goods and volumes can be found within the ITT documents.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=OCT397234 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Not specified |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 13 Oct 2020 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 13 Oct 2020 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Cancelled |
| Lots status | Cancelled |
| Awards status | Unsuccessful |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS") |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 13 Oct 2020 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=OCT397234

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=OCT397234
  Cytokine Modulators - Supply of Cytokine Modulators to NHS Scotland. etanercept infliximab adalimumab methotrexate The goods have been split into eight (8) categories, each of which are identified as a 'Lot'. Full details of each Lot are contained in section II.2) of this notice.

## Notice URLs

- http://
- http://www.nhsscotlandprocurement.scot.nhs.uk/
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000633256
- https://ted.europa.eu/udl?uri=TED:NOTICE:483802-2020:TEXT:EN:HTML
- https://www.scotcourts.gov.uk

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000633256. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000633256.json.